Tissue Engineering Measurands

被引:12
作者
Arora, Deepika [1 ]
Babakhanova, Greta [1 ]
Simon, Carl G., Jr. [1 ]
机构
[1] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA
关键词
tissue engineering; measurand; standards; metrology; cell viability; scaffold; potency; biocompatibilitv; measurement; STANDARDS;
D O I
10.1021/acsbiomaterials.0c00475
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
A metrological perspective for thinking about the characterization of tissue engineered medical products (TEMPs) may help improve communication between researchers. During the development lifecycle of a TEMP, many product properties are measured over the long path to a product release. The selection of each measurement is designed to establish that the product is safe and efficacious (i.e., successful). However, there is often miscommunication during discussions of product characterization. The miscommunication stems from inherent assumptions that are made about the measurements. A "measurand chart" can help clarify these assumptions to enable a more coherent discussion of the value of each measurement. A measurand is defined as "the quantity or property intended to be measured". Tissue engineering measurands are discussed in terms of three case studies including "cell viability in a scaffold", "potency", and "biocompatibility". Topics including a measurement model, defining tissue engineering measurands and definitional uncertainty, are discussed to further refine thinking about tissue engineering measurands. Awareness of these concepts while discussing product characterization can enhance communication and strategic thinking so that the resulting plan is clear and purposeful.
引用
收藏
页码:5368 / 5376
页数:9
相关论文
共 33 条
[1]   PicoGreen quantitation of DNA: Effective evaluation of samples pre- or post-PCR [J].
Ahn, SJ ;
Costa, J ;
Emanuel, JR .
NUCLEIC ACIDS RESEARCH, 1996, 24 (13) :2623-2625
[2]  
[Anonymous], 2018, Use of International Standard ISO 10993-1
[3]  
[Anonymous], 2016, 109936 ISO
[4]  
[Anonymous], 2005, Validation of analytical procedures: Text and methodology Q2 (R1)
[5]  
[Anonymous], 2011, Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products,
[6]   FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products [J].
Arcidiacono, Judith A. ;
Bauer, Steven R. ;
Kaplan, David S. ;
Allocca, Clare M. ;
Sarkar, Sumona ;
Lin-Gibson, Sheng .
CYTOTHERAPY, 2018, 20 (06) :779-784
[7]  
ASTM, 2019, F3368 ASTM INT
[8]  
ASTM, 2019, F2739 ASTM INT
[9]   Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry [J].
Bravery, Christopher A. ;
Carmen, Jessica ;
Fong, Timothy ;
Oprea, Wanda ;
Hoogendoorn, Karin H. ;
Woda, Juliana ;
Burger, Scott R. ;
Rowley, Jon A. ;
Bonyhadi, Mark L. ;
Van't Hof, Wouter .
CYTOTHERAPY, 2013, 15 (01) :9-19
[10]   Life, Death, and In-Between: Meanings and Methods in Microbiology [J].
Davey, Hazel M. .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2011, 77 (16) :5571-5576